Development of Mucosal and Systemic Lymphoproliferative Responses and Protective Immunity to Human Group A Rotaviruses in a Gnotobiotic Pig Model
Overview
Affiliations
Gnotobiotic pigs were orally inoculated with virulent Wa strain (G1P1A[8]) human rotavirus (group 1), attenuated Wa rotavirus (group 2) or diluent (controls) and were challenged with virulent Wa rotavirus 21 days later. On various postinoculation or postchallenge days, virus-specific responses of systemic (blood and spleen) and intestinal (mesenteric lymph node and ileal lamina propria) mononuclear cells (MNC) were assessed by lymphoproliferative assays (LPA). After inoculation, 100% of group 1 pigs and 6% of group 2 pigs shed virus. Diarrhea occurred in 95, 12, and 13% of group 1, group 2, and control pigs, respectively. Only groups 1 and 2 developed virus-specific LPA responses prior to challenge. Group 1 developed significantly greater mean virus-specific LPA responses prior to challenge and showed no significant changes in tissue mean LPA responses postchallenge, and 100% were protected against virulent virus challenge. By comparison, both group 2 and controls had significantly lower LPA responses at challenge and both groups showed significant increases in mean LPA responses postchallenge. Eighty-one percent of group 2 and 100% of control pigs shed challenge virus, and both groups developed diarrhea that was similar in severity postchallenge. The virus-specific LPA responses of blood MNC mirrored those of intestinal MNC, albeit at a reduced level and only at early times postinoculation or postchallenge in all pigs. In a separate study evaluating antibody-secreting-cell responses of these pigs (L. Yuan, L.A. Ward, B.I. Rosen, T.L. To, and L.J. Saif, J. Virol. 70:3075-3083, 1996), we found that the magnitude of a tissue's LPA response positively correlated with the numbers of virus-specific antibody-secreting cells for that tissue, supporting the hypothesis that the LPA assesses T-helper-cell function. The magnitude of LPA responses in systemic and intestinal tissues also strongly correlated with the degree of protective immunity elicited by the inoculum (p = 0.81). We conclude that blood may provide a temporary "window" for monitoring intestinal T cells and that the LPA can be used to assess protective immunity to human rotaviruses.
Michael H, Srivastava V, Deblais L, Amimo J, Chepngeno J, Saif L mSphere. 2022; 7(5):e0027022.
PMID: 36073800 PMC: 9599269. DOI: 10.1128/msphere.00270-22.
Alhamo M, Boley P, Liu M, Niu X, Yadav K, Lee C Viruses. 2022; 14(6).
PMID: 35746696 PMC: 9230012. DOI: 10.3390/v14061225.
Parenteral, non-live rotavirus vaccine: recent history and future perspective.
Song J Clin Exp Vaccine Res. 2021; 10(3):203-210.
PMID: 34703802 PMC: 8511589. DOI: 10.7774/cevr.2021.10.3.203.
Michael H, Paim F, Miyazaki A, Langel S, Fischer D, Chepngeno J PLoS One. 2021; 16(2):e0246193.
PMID: 33592026 PMC: 7886176. DOI: 10.1371/journal.pone.0246193.
Suda Y, Miyazaki A, Miyazawa K, Shibahara T, Ohashi S Vet Res. 2021; 52(1):2.
PMID: 33397461 PMC: 7780908. DOI: 10.1186/s13567-020-00880-z.